Clinical implications of epidemiologic data for diagnosis and treatment of psychiatric comorbidity

Psychiatric Annals

Volumn 38, Issue 11, 2008, Pages 709-715

  Samet, Sharon ^a,b   Hasin, Deborah ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Columbia University School of Social Work ^*

Author keywords

[No Author keywords available]

Indexed keywords

EID: 56849105486     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/00485713-20081101-10     Document Type: Review

References (78)

1. Hasin D. Nunes E. Meydan K. Comorbidity of alcohol, drug, and psychiatric disorders: epidemiology. In: Kranzler HR, Tinsley JA, eds. Dual Diagnosis and Psychiatric Treatment: Substance Abuse and Comorbid Disorders. New York: Mercel Dekker; 2004:1-34.
2. Regier DA, Myers JK, Kramer M, et al. The NIMH Epidemiologic Catchment Area program. Historical context, major objectives, and study population characteristics. Arch Gen Psychiatry. 1984;41(10):934-941.
3. Kessler RC, McGonagle KA, Zhao S, et al. Life-time and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51(1):8-19.
4. Grant BF, Harford TC. Comorbidity between DSM-IV alcohol use disorders and major depression: results of a national survey. Drug Alcohol Depend. 1995;39(3):197-206.
5. Grant BF, Stinson FS, Dawson DA, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61(8):807-816.
6. Kessler RC, Berglund P, Demler O, Jin R, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593-602.
7. Hasin DS, Stinson FS, Ogburn E, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2007;64(7):830-842.
8. Regier D, Farmer M, Rae D, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) study. JAMA. 1990;264(19):2511-2518.
9. Kessler RC, Zhao S, Blazer DG, Swartz M. Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey. J Affect Disord. 1997;45(1-2):19-30.
10. Hasin DS, Goodwin RD, Stinson FS, Grant BF. Epidemiology of major depressive disorder results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry. 2005;62(10):1097-1106.
11. Brady KT, Grice DE, Dustan L, Randall C. Gender differences in substance use disorders. Am J Psychiatry. 1993;150(11):1707-1711.
12. Schuckit MA, Tipp JE, Bergman M, Reich W, Hesselbrock VM, Smith TL. Comparison of induced and independent major depressive disorders in 2,945 alcoholics. Am J Psychiatry. 1997;154(7):948-957.
13. Merikangas KR, Stevens DE, Fenton B, et al. Co-morbidity and familial aggregation of alcoholism and anxiety disorders. Psychol Med. 1998;28(4):773-788.
14. Swendsen JD, Merikangas KR, Canino GJ, Kessler RC, Rubio-Stipec M, Angst J. The comorbidity of alcoholism with anxiety and depressive disorders in four geographic communities. Compr Psychiatry. 1998;39(4):176-184.
15. Verheul R, Kranzler HR, Poling J, Tennen H, Ball S, Rounsaville BJ. Co-occurrence of Axis I and Axis II disorders in substance abusers. Acta Psychiatr Scand. 2000;101(2):110-118.
16. Nunes EV, Levin FR. Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis. JAMA. 2004;291(15):1887-1896.
17. Dawson DS, Grant BF, Stinson FS, Chou PS. Psychopathology associated with drinking and alcohol use disorders in the college and general adult populations. Drug Alcohol Depend. 2005;77(2):139-150.
18. Kushner MG, Sher KJ, Beitman BD. The relation between alcohol problems and the anxiety disorders. Am J Psychiatry. 1990;147(6):685-695.
19. Kushner MG, Abrams K, Borchardt C. The relationship between anxiety disorders and alcohol use disorders: a review of major perspectives and findings. Clin Psychol Rev. 2000;20(2):149-171.
20. Jacobsen LK, Southwick SM, Kosten TR. Substance use disorders in patients with posttraumatic stress disorder: a review of the literature. Am J Psychiatry. 2001;158(8):1184-1190.
21. Kessler RC, Nelson CB, McGonagle KA, Liu J, Swartz M, Blazer DG. Comorbidity of DSM-IIIR major depressive disorder in the general population: results from the U.S. National Comorbidity Survey. Br J Psychiatry Suppl. 1996;30:17-30.
22. O'Brien CP, Charney DS, Lewis L, et al. Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to action. Biol Psychiatry. 2004;56(10):703-713.
23. Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617-627.
24. Kessler RC, Demler O, Frank RG, et al. Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med. 2005;352(24):2515-2523.
25. Grant BF. Comorbidity between DSM-IV drug use disorders and major depression: results of a national survey of adults. J Subst Abuse. 1995;7(4):481-497.
26. Hasin D, Van Rossem R, McCloud S, Endicott J. Alcohol dependence and abuse diagnoses: validity in community sample heavy drinkers. Alcohol Clin Exp Res. 1997;21(2):213-219.
27. Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2007;64(5):566-576.
28. Chen CY, Wagner F, Anthony J. Marijuana use and the risk of major depressive episode: epidemiological evidence from the United States National Comorbidity Survey. Social Psychiatry and Psychiatric Epidemiology. 2002;37(5):199-206.
29. Conway KP, Compton W, Stinson FS, Grant BF. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2006;67(2):247-257.
30. Stinson FS, Ruan WJ, Pickering R, Grant BF. Cannabis use disorders in the USA: prevalence,correlates and co-morbidity. Psychological Medicine. 2006;36(10):1447-1460.
31. Weller RA, Halikas JA. Marijuana use and psychiatric illness: a follow-up study. Am J Psychiatry. 1985;142(7):848-850.
32. Angst J. Comorbidity of mood disorders: a longitudinal prospective study. Br J Psychiatry Suppl. 1996;30:31-37.
33. Bovasso GB. Cannabis abuse as a risk factor for depressive symptoms. Am J Psychiatry. 2001;158(12):2033-2037.
34. Gawin FH, Ellinwood EH. Cocaine and other stimulants. Actions, abuse, and treatment. N Engl J Med. 1988;318(18):1173-1182.
35. Anthony JC, Tien AY, Petronis KR. Epidemiologic evidence on cocaine use and panic attacks. Am J Epidemiol. 1980;129(3):543-549.
36. Rounsaville BJ, Anton SF, Carroll K, Budde D, Prusoff BA, Gawin F. Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch Gen Psychiatry. 1991;48(1):43-51.
37. Rounsaville BJ.Treatment of cocaine dependence and depression. Biol Psychiatry. 2004;56(10):803-809.
38. Carroll KM, Rounsaville BJ. Contrast of Treatment seeking and untreated cocaine abusers. Arch Gen Psychiatry. 1992;49(6):464-471.
39. Weiss RD, Marin SM, Griffin ML. Methodological Considerations in the diagnosis of co-existing psychiatric disorders in drug abusers. British Journal of Addiction. 1992;87:179-187.
40. Gawin FH, Kleber HD. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers: clinical observations. Arch Gen Psychiatry. 1986;43(2):107-113.
41. Helmus TC, Downey KK, Wang LM, Rhodes GL, Schuster CR. The relationship between self-reported cocaine withdrawal symptoms and history of depression. Addictive Behaviors. 2001;26(3):461-467.
42. Goodwin RD, Stayner DA, Chinman MJ, Ping W, Tebes JK, Davidson L. The relationship between anxiety and substance use disorders among individuals with severe affective disorders. Compr Psychiatry. 2002;43(4):245-252.
43. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
44. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Text revision. Washington, DC: American Psychiatric Association; 2000.
45. Hasin D, Samet S, Nunes E, Meydan J, Matseoane K, Waxman R. Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV. Am J Psychiatry. 2006;163(4):689-696.
46. Torrens M, Serrano D, Astals M, Pérez-Domínguez G, Martín-Santos R. Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV. Am J Psychiatry. 2004;161(7):1231-1237.
47. Lichtman AH, Martin BR. Cannabinoid tolerance and dependence. Handb Exp Pharmacol. 2005;(168):691-717.
48. Wiesbeck GA, Schuckit MA, Kalmijn JA, Tipp JE, Bucholz KK, Smith TL: An evaluation of the history of a marijuana withdrawal syndrome in a large population. Addiction. 1996;91(10):1469-1478.
49. Budney AJ, Novy P, Hughes J. Marijuana withdrawal among adults seeking treatment for marijuana dependence. Addiction. 1999;94(9):1311-1321.
50. Budney AJ, Moore BA, Vandreu RG, et al. The time course and significance of cannabis withdrawal. J Abnorm Psychol. 2003;112(3):393-402.
51. Haney M, Ward AS, Comer SD, Foltin RW, Fischman MW. Abstinence symptoms following smoked marijuana in humans. Psychopharmacology (Berl). 1999;141(4):395-404.
52. Hasin D. Alcohol and exposure to terrorism. European Neuropsychopharmacology. 2008;18(4):S181.
53. Budney AJ, Hughes JR, Moore BA, Vandrey R. Review of the validity and significance of cannabis withdrawal syndrome. Am J Psychiatry. 2004;161(11)1967-1977.
54. Hasin DS, Grant BF. Major depression in 6050 former drinkers: association with past alcohol dependence. Arch Gen Psychiatry. 2002;59(9):794-800.
55. Helping Patients Who Drink Too Much: A Clinician's Guide. National Institute on Alcohol Abuse and Alcoholism.2005. Available at: http://www.niaaa.nih.gov/Publications/EducationTraining-Materials/guide.htm.
56. Samet S, Zweben A, Hasin D. Major depression and anxiety disorder in abstainers and non-risk drinkers. Abstracts of the 2008 Joint Scientific Meeting of the Research Society on Alcoholism and the International Society for Biomedical Research on Alcoholism, Washington, DC. Alcohol Clin Exp Res. 2008;32(6):9A-366A.
57. Hasin D, Liu X, Nunes E, McCloud S, Samet S, Endicott J. Effects of major depression on remission and relapse of substance dependence. Arch Gen Psychiatry. 2002;59(4):375-380.
58. Cornelius JR, Maisto SA, Martin CS, et al. Major depression associated with earlier alcohol relapse in treated teens with AUD. Addict Behav. 2004;29(5):1035-1038.
59. Carpenter KM, Hasin DS. Drinking to cope with negative affect and DSM-IV alcohol use disorders: a test of three alternative explanations. J Stud Alcohol. 1999;60(5):694-704.
60. Beseler C, Hasin D. Drinking after 9/11/01: the influence of physical exposure and earlier drinking motives. In press.
61. Beseler CL, Aharonovich E, Keyes KM, Hasin DS. Adult transition from at-risk drinking to alcohol dependence: the relationship of family history and drinking motives. Alcohol Clin Exp Res. 2008;32(4):607-616.
62. Kushner MG, Abrams K, Thuras P, Hanson KL, Brekke M, Sletten S. Follow-up study of anxiety disorder and alcohol dependence in comorbid alcoholism treatment patients. Alcohol Clin Exp Res. 2005;29(8):1432-1443.
63. Tómasson K, Vaglum P. The role of psychiatric comorbidity in the prediction of readmission for detoxification. Compr Psychiatry. 1998;39(3):129-136.
64. Zimmerman P. Wittchen HU. Hofler M. Pfister H. Kessler RC. Lieb R. Primary anxiety disorders and the development of subsequent alcohol use disorders: a 4-year community study of adolescents and young adults. Psychol Med. 2003;33(7):1211-1222.
65. Budney AJ, Roffman R, Stephens RS, Walker D. Marijuana dependence and its treatment. Addict Sci Clin Pract. 2007;4(1):4-16.
66. Substance Abuse and Mental Health Services Administration, Treatment Episode Data Set (TEDS): 1992-2002. National Admissions to Substance Abuse Treatment Services. DHHS Publication No. SMA 04-3965. Rockville, MD: Department of Health and Human Services; 2004.
67. Degenhardt L, Hall W, Lynskey M. Exploring the association between cannabis use and depression. Addiction. 2003;98(11):1493-1504.
68. Moore TH, Zammit S, Lingford-Hughes A, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007;370(9584):319-328.
69. Georgiades K, Boyle MH. Adolescent tobacco and cannabis use: young adult outcomes from the Ontario Child Health Study. J Child Psychol Psychiatry. 2007;48(7):724-731.
70. Harder VS, Stuart EA, Anthony JC. Adolescent cannabis problems and young adult depression: male-female stratified propensity score analyses. Am J Epidemiol. 2008168(6):592-601.
71. White AM, Jordan JD, Schroeder KM, et al. Predictors of relapse during treatment and treatment completion among marijuana-dependent adolescents in an intensive outpatient substance abuse program. Subst Abus. 2004;25(1):53-59.
72. Hasin DS, Keyes KM, Alderson D, Wang S, Aharonovich E, Grant BF. Cannabis withdrawal in the United States: a general population study. J Clin Psychiatry. In press.
73. Thomas H. A community survey of adverse effects of cannabis use. Drug and Alcohol Dependence. 1996;42:201-207.
74. Schuckit MA. Comorbidity between substance use disorders and psychiatric conditions. Addiction. 2006;101(Suppl 1):76-88.
75. McKetin R, McLaren J, Lubman DI, et al. The prevalence of psychotic symptoms among methamphetamine users. Addiction. 2006;101(10):1473-1478.
76. Smit F, Bolier L, Cuijpers P. Cannabis use and the risk of later schizophrenia: a review. Addiction. 2004;99(4):425-430.
77. Caton CL, Drake RE, Hasin DS, et al. Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses. Arch Gen Psychiatry. 2005;62(2):137-145.
78. Caton CL, Hasin DS, Shrout PE, et al. Stability of early-phase primary psychotic disorders with concurrent substance use and substance-induced psychosis. Br J Psychiatry. 2007;190:105-111.